Targeting Bcl-2 Protein to Enhance Chemosensitivity of Hormone Refractory Prostate Cancer Cell Line, DU-145 by a Synergistic Combination of Docetaxel and Gossypol
Abstract:A AB BS S T TR RA AC CT T O Ob b j je ec c t ti i v ve e: : Do ce ta xel has be co me the stan dard of ca re for hor mo ne-ref rac tory pros tate can cer (HRPC), ho we ver drug re sis tan ce and to xi city are still chal len ging in da ily can cer practi ce. The an ti-apop to tic path way cen te red aro und the Bcl-2 pro te in might be one of the res pon sib le path ways. Ad ding a se cond drug to do ce ta xel tre at ment is one of the most com mon ap pro ac hes to sol ve this prob lem. Goss ypol was re por te… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.